Hoboken, N.J., October 17, 2007—John Wiley & Sons, Inc, (NYSE:JWa) (NYSE:JWb), today announced that Nobel laureates in Chemistry, Physics, Economics, and Medicine are Wiley authors.
“Congratulations to Dr. Gerhard Ertl, Dr. Mario R. Capecchi, Sir Martin Evans, Dr. Albert Fert, Dr. Peter Grünberg, Leonid Hurwicz, Dr. Erik Maskin, Dr. Roger Myerson, and Dr. Oliver Smithies on this recognition of their great achievements. We are honored and proud that they are members of Wiley’s author community, along with more than 350 other Nobel laureates who have published with us. Collaborating with this esteemed group of Nobel laureates reflects Wiley’s unwavering commitment to publishing cutting-edge research and sharing it with readers around the world,” said William J. Pesce, Wiley's President and Chief Executive Officer.
Dr. Gerhard Ertl, of Germany, has received the Nobel Prize in Chemistry for his studies of chemical processes on solid surfaces. Dr. Ertl is co-editor of the eight-volume Handbook of Heterogeneous Catalysis, to appear in early 2008, and serves on the editorial boards of Chemistry — A European Journal and ChemPhysChem, which are published by Wiley-VCH together with numerous European Chemical Societies.
Leonid Hurwicz, Dr. Erik Maskin, and Dr. Roger Myerson, all of the USA, were awarded the Nobel Prize in Economics for laying the foundations of mechanism design theory. All three Nobel laureates write for a variety of Wiley-Blackwell journals.
Dr. Peter Grünberg, of Germany, and Dr. Albert Fert, of France, were jointly awarded the Nobel Prize in Physics for the discovery of Giant Magnetoresistance. Dr. Grünberg recently published a highly-cited review article in the Physik Journal, on behalf of Germany’s Physical Society, the world’s largest physical society. With his colleagues, Dr. Fert has coauthored several articles that appear in Wiley-Blackwell journals.
Dr. Mario R. Capecchi of the USA, Sir Martin Evans of the UK, and Dr. Oliver Smithies of the USA were awarded the Nobel Prize in Medicine for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells. The Nobel Prize winners have contributed articles to Wiley-Blackwell journals, and Sir Martin Evans is also on the editorial board of the Encyclopaedia of Molecular Cell Biology and Molecular Medicine.
About Wiley-Blackwell
Wiley-Blackwell was formed in February 2007 as a result of the acquisition of Blackwell Publishing Ltd. by John Wiley & Sons, Inc., and its merger with Wiley’s Scientific, Technical, and Medical business. Together, the companies have created a global publishing business with deep strength in every major academic and professional field. Wiley-Blackwell publishes approximately 1,400 scholarly peer-reviewed journals and an extensive collection of books with global appeal. For more information on Wiley-Blackwell, please visit www.blackwellpublishing.com or http://interscience.wiley.com.
About Wiley
Founded in 1807, John Wiley & Sons, Inc. has been a valued source of information and understanding for 200 years, helping people around the world meet their needs and fulfill their aspirations. Since 1901, Wiley and its acquired companies have published the works of more than 350 Nobel laureates in all categories: Literature, Economics, Physiology/Medicine, Chemistry and Peace.
Our core businesses include scientific, technical, medical and scholarly journals, encyclopedias, books, and online products and services; professional/trade publishes books, subscription products, training materials, and online applications and websites; and educational materials for undergraduate and graduate students and lifelong learners. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company’s Web site can be accessed at http://www.wiley.com. The Company is listed on the New York Stock Exchange under the symbols JWa and JWb.